CIK 0001707502
- Non-accelerated filer
- Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900943402
- Phone
- +1 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-16 | SMITH IAN F Director | Grant or award · Director Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2020-06-16 | Sullivan Lynne Marie Director | Grant or award · Director Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-06-16 | Shah Rajeev M. Director | Grant or award · Director Stock Option (Right to But) | +30,000 | 30,000 | ||
| 2020-06-16 | Nagendran Sukumar Director | Grant or award · Director Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-06-16 | Nagendran Sukumar Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-16 | Huffines Robert Luther Director | Grant or award · Director Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-06-16 | Freed Martin I Director | Grant or award · Director Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-06-16 | Freed Martin I Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-16 | Arnold Matthew Bennett Director | Grant or award · Director Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-06-16 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-06-16 | Stone Adam Leo Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-06-16 | Koppel Adam Director | Grant or award · Director Stock Option (Right To Buy) | +30,000 | 30,000 | ||
| 2020-06-16 | Koppel Adam Director | Grant or award · Director Stock Option (Right To Buy) | +10,000 | 10,000 | ||
| 2020-04-15 | SMITH IAN F Director | Grant or award · Director Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-03-11 | Schneider Joel Solomon Zev Chief Technology Officer | Grant or award | +75,000 | 201,656 | ||
| 2020-03-11 | Morris Carl Ashley Chief Scientific Officer | Grant or award | +75,000 | 208,050 | ||
| 2020-03-11 | Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy | Grant or award | +75,000 | 244,700 | ||
| 2020-03-11 | HERSCHA LYNETTE Chief Legal Officer | Grant or award | +75,000 | 75,000 | ||
| 2020-02-14 | Ganot Ilan CEO & President | Shares withheld for taxes | −293 | $3.15 | $923 | 2,937 |
| 2020-02-12 | Ganot Ilan CEO & President | Exercise or conversion | +800 | 3,230 |
Page 25 of 31 · 604 trades